• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.

作者信息

Blum Sabine, Dunet Vincent, Comoli Patrizia, Tirefort Yordanka, Chalandon Yves, Opota Onya, Comte Denis, Spertini Olivier, Livio Françoise, Brouland Jean Philippe, Du Pasquier Renaud

机构信息

Service and Central Laboratory of Hematology, Oncology Department, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

Leuk Lymphoma. 2020 Sep;61(9):2226-2229. doi: 10.1080/10428194.2020.1759052. Epub 2020 May 4.

DOI:10.1080/10428194.2020.1759052
PMID:32364409
Abstract
摘要

相似文献

1
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.一名FIP1L1-PDGFRA阳性髓系肿瘤患者停用伊马替尼后病情缓解的进行性多灶性白质脑病
Leuk Lymphoma. 2020 Sep;61(9):2226-2229. doi: 10.1080/10428194.2020.1759052. Epub 2020 May 4.
2
Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.伊马替尼治疗与呈现FIP1L1-PDGFRA融合基因的骨髓增殖性嗜酸性粒细胞增多综合征相关的淋巴瘤样丘疹病。
Acta Derm Venereol. 2017 Jul 6;97(7):855-857. doi: 10.2340/00015555-2669.
3
A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.一例伴有嗜酸性粒细胞增多和FIP1L1::PDGFRA重排的髓系/淋系肿瘤的疑难诊断。
Blood. 2023 May 18;141(20):2541. doi: 10.1182/blood.2022019573.
4
Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.因携带FIP1L1-PDGFRA转录本的嗜酸性粒细胞增多综合征而停用伊马替尼。
Leuk Lymphoma. 2016;57(3):708-10. doi: 10.3109/10428194.2015.1065983. Epub 2015 Oct 2.
5
[Acute myeloid leukemia with FIP1L1-PDGFRA fusion gene treated with imatinib: a case report and literature review].[伊马替尼治疗伴有FIP1L1-PDGFRA融合基因的急性髓系白血病：1例报告并文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):1044-1046. doi: 10.3760/cma.j.issn.0253-2727.2020.12.014.
6
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.携带FIP1L1-PDGFRA突变的嗜酸性粒细胞增多性髓系肿瘤的下一代测序
Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11.
7
Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder.尽管FIP1L1-PDGFRA融合基因阳性的高嗜酸性粒细胞增多症患者已达到分子缓解，但伊马替尼维持治疗似乎仍有必要。
Leuk Res. 2008 Jan;32(1):169-71. doi: 10.1016/j.leukres.2007.04.004. Epub 2007 Jun 4.
8
[FIP1L1-PDGFRalpha-positive myeloproliferative disease with hypereosinophilia: clinical characteristics and pathogenetic therapy].[伴有嗜酸性粒细胞增多的FIP1L1-PDGFRα阳性骨髓增殖性疾病：临床特征与致病治疗]
Ter Arkh. 2005;77(7):90-2.
9
Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.以溶骨性病变为首发表现的FIP1L1-PDGFRA重排的嗜酸性粒细胞增多性髓系/淋巴系肿瘤：一例报告
Ann Hematol. 2024 Jan;103(1):357-360. doi: 10.1007/s00277-023-05485-y. Epub 2023 Sep 30.
10
A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome.一种新型FIP1L1-PDGFRA突变体，可破坏慢性嗜酸性粒细胞白血病/高嗜酸性粒细胞综合征中激酶结构域的非活性构象。
Allergy. 2009 Jun;64(6):913-8. doi: 10.1111/j.1398-9995.2009.01943.x. Epub 2009 Feb 7.